The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?
Open accessAbstract
Sepsis remains the leading cause of death in most intensive care units. Advances in understanding the immune response to sepsis provide the opportunity to develop more effective therapies. The immune response in sepsis can be characterized by a cytokine-mediated hyper-inflammatory phase, which most patients survive, and a subsequent immune-suppressive phase. Patients fail to eradicate invading pathogens and are susceptible to opportunistic organisms in the hypo-inflammatory phase. Many mechanisms are responsible for sepsis-induced immuno-suppression, including apoptotic depletion of immune cells, increased T regulatory and myeloid-derived suppressor cells, and cellular exhaustion. Currently in clinical trial for sepsis are granulocyte macrophage colony stimulating factor and interferon gamma, immune-therapeutic agents that boost patient immunity. Immuno-adjuvants with promise in clinically relevant animal models of sepsis include anti-programmed cell death-1 and interleukin-7. The future of immune therapy in sepsis will necessitate identification of the immunologic phase using clinical and laboratory parameters as well as biomarkers of innate and adaptive immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Self-citationGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866
Evolving functions of endothelial cells in inflammation
Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781
Self-citationSharpe, A. H., & Freeman, G. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri727 · Cited by 1,712
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,442
Self-citationApoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G., & Karl, I. E. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00002 · Cited by 1,340
Self-citationMonocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Hotchkiss, R. S., Strasser, A., McDunn, J. E., & Swanson, P. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0901217 · Cited by 1,154
Self-citationTh17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039
Sir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989
Interleukin 15: biology and relevance to human disease
Fehniger, T. A., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.1.14 · Cited by 976
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Schmieg, R. E., Hui, J. J., Chang, K. C., Osborne, D. F., Freeman, B. D., Cobb, J. P., Buchman, T. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6952 · Cited by 934
Self-citationDrotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
Abraham, E., Laterre, P.-F., Garg, R., Levy, H., Talwar, D., Trzaskoma, B. L., François, B., Guy, J. S., Brückmann, M., Rea-Neto, Á., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050935 · Cited by 890
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883
Gogos, C. A., Drosou, E., Bassaris, H. P., & Skoutelis, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315214 · Cited by 882
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
DIVERSE FUNCTIONS OF IL-2, IL-15, AND IL-7 IN LYMPHOID HOMEOSTASIS
Ma, A., Koka, R., & Burkett, P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090727 · Cited by 829
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
Dysregulation of in vitro cytokine production by monocytes during sepsis.
Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J. P., & Cavaillon, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115493 · Cited by 754
Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., O'Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062602 · Cited by 652
Meisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0363oc · Cited by 648
T‐cell exhaustion: characteristics, causes and conversion
Yi, J. S., Cox, M. A., & Zajac, A. J. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03255.x · Cited by 645
The sepsis seesaw: tilting toward immunosuppression
Hotchkiss, R. S., Coopersmith, C. M., McDunn, J. E., & Ferguson, T. A. (2009) · Nature Medicine · doi:10.1038/nm0509-496 · Cited by 574
Self-citationNgiow, S. F., von Scheidt, B., Akiba, H., Yagita, H., Teng, M. W. L., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0096 · Cited by 574
The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance
Fry, T. J., & Mackall, C. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6571 · Cited by 563
Host–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 553
Adoptive T cell therapy for cancer in the clinic
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32446 · Cited by 553
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
Strasser, A., Cory, S., & Adams, J. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.307 · Cited by 532
Normal Responses to Injury Prevent Systemic Inflammation and Can Be Immunosuppressive
MUNFORD, R. S., & PUGIN, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2007102 · Cited by 522
Huang, X., Venet, F., Wang, Y. L., Lepape, A., Yuan, Z., Chen, Y., Swan, R., Kherouf, H., Monneret, G., Chung, C.-S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809422106 · Cited by 515
Nadel, S., Goldstein, B., Williams, M. D., Dalton, H., Peters, M., Macias, W. L., Abd-Allah, S. A., Levy, H., Angle, R., Wang, D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60411-5 · Cited by 501
Delayed Hypersensitivity: Indicator of Acquired Failure of Host Defenses in Sepsis and Trauma
MEAKINS, J. L., PIETSCH, J. B., BUBENICK, O., KELLY, R., RODE, H., GORDON, J., & MACLEAN, L. D. (1977) · Annals of Surgery · doi:10.1097/00000658-197709000-00002 · Cited by 486
Anti-inflammatory cytokine profile and mortality in febrile patients
VANDISSEL, J., VANLANGEVELDE, P., WESTENDORP, R., KWAPPENBERG, K., & FROLICH, M. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80013-6 · Cited by 482
Sportès, C., Hakim, F. T., Memon, S. A., Zhang, H., Chua, K. S., Brown, M. R., Fleisher, T. A., Krumlauf, M. C., Babb, R. R., Chow, C. K., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071681 · Cited by 476
Systemic inflammatory response syndrome
Davies, M. G., & Hagen, P.-O. (1997) · Journal of British Surgery · doi:10.1002/bjs.1800840707 · Cited by 456
Prevention of lymphocyte cell death in sepsis improves survival in mice
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14541 · Cited by 454
Self-citationDownregulation of proinflammatory cytokine release in whole blood from septic patients
Ertel, W., Kremer, J., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O., & Schildberg, F. (1995) · Blood · doi:10.1182/blood.v85.5.1341.bloodjournal8551341 · Cited by 445
Rosenberg, S. A., Sportès, C., Ahmadzadeh, M., Fry, T. J., Ngo, L. T., Schwarz, S. L., Stetler-Stevenson, M., Morton, K. E., Mavroukakis, S. A., Morre, M., et al. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000210386.55951.c2 · Cited by 443
The late phase of sepsis is characterized by an increased microbiological burden and death rate
Otto, G. P., Sossdorf, M., Claus, R. A., Rödel, J., Menge, K., Reinhart, K., Bauer, M., & Riedemann, N. C. (2011) · Critical Care · doi:10.1186/cc10332 · Cited by 434
The systemic inflammatory response syndrome
Meeran, H., & Messent, M. (2001) · Trauma · doi:10.1177/146040860100300203 · Cited by 425
Wang, H., & Ma, S. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2007.10.031 · Cited by 408
Molecular biology of inflammation and sepsis: A primer*
Cinel, I., & Opal, S. M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819267fb · Cited by 387
Panacek, E. A., Marshall, J. C., Albertson, T. E., Johnson, D. H., Johnson, S., MacArthur, R. D., Miller, M., Barchuk, W. T., Fischkoff, S., Kaul, M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145229.59014.6c · Cited by 387
Immunotherapy for Sepsis — A New Approach against an Ancient Foe
Hotchkiss, R. S., & Opal, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmcibr1004371 · Cited by 367
Self-citationInterleukin-15 biology and its therapeutic implications in cancer
Steel, J. C., Waldmann, T. A., & Morris, J. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.004 · Cited by 361
Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome
Hall, M. W., Knatz, N. L., Vetterly, C., Tomarello, S., Wewers, M. D., Volk, H. D., & Carcillo, J. A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2088-x · Cited by 355
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
Sereti, I., Dunham, R. M., Spritzler, J., Aga, E., Proschan, M. A., Medvik, K., Battaglia, C. A., Landay, A. L., Pahwa, S., Fischl, M. A., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186601 · Cited by 342
Twelve immunotherapy drugs that could cure cancers
‘Mac’ Cheever, M. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00604.x · Cited by 341
Guignant, C., Lepape, A., Huang, X., Kherouf, H., Denis, L., Poitevin, F., Malcus, C., Chéron, A., Allaouchiche, B., Gueyffier, F., et al. (2011) · Critical Care · doi:10.1186/cc10112 · Cited by 325
Venet, F., Chung, C.-S., Kherouf, H., Geeraert, A., Malcus, C., Poitevin, F., Bohé, J., Lepape, A., Ayala, A., & Monneret, G. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1337-8 · Cited by 320
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
Unsinger, J., McGlynn, M., Kasten, K. R., Hoekzema, A. S., Watanabe, E., Muenzer, J. T., McDonough, J. S., Tschoep, J., Ferguson, T. A., McDunn, J. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903151 · Cited by 312
Self-citationZhang, Y., Zhou, Y., Lou, J., Li, J., Bo, L., Zhu, K., Wan, X., Deng, X., & Cai, Z. (2010) · Critical Care · doi:10.1186/cc9354 · Cited by 308
Brahmamdam, P., Inoue, S., Unsinger, J., Chang, K. C., McDunn, J. E., & Hotchkiss, R. S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0110037 · Cited by 305
Self-citationAbraham, E., Laterre, P.-F., Garbino, J., Pingleton, S., Butler, T., Dugernier, T., Margolis, B., Kudsk, K., Zimmerli, W., Anderson, P., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200103000-00006 · Cited by 293
An Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283
Self-citationStandiford, T. J., Strieter, R. M., Lukacs, N. W., & Kunkel, S. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2222 · Cited by 275
Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting?
Dyson, A., & Singer, M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181922bd3 · Cited by 273
Senftleben, U., & Karin, M. (2002) · PubMed · Cited by 272
The Search for Effective Therapy for Sepsis: Back to the Drawing Board?
Angus, D. C. (2011) · JAMA · doi:10.1001/jama.2011.1853 · Cited by 264
Principles of adoptive T cell cancer therapy
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31446 · Cited by 261
Humes, H. D., Weitzel, W. F., Bartlett, R. H., Swaniker, F. C., Paganini, E. P., Luderer, J. R., & Sobota, J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00923.x · Cited by 256
Regulation of Immune Responses by T Cells
Jiang, H., & Chess, L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055446 · Cited by 253
Senftleben, U., & Karin, M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00003 · Cited by 244
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis
Boomer, J. S., Shuherk-Shaffer, J., Hotchkiss, R. S., & Green, J. M. (2012) · Critical Care · doi:10.1186/cc11404 · Cited by 243
Self-citationLévy, Y., Sereti, I., Tambussi, G., Routy, J. P., Lelièvre, J. D., Delfraissy, J. F., Molina, J. M., Fischl, M., Goujard, C., Rodriguez, B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis383 · Cited by 240
Kollef, K. E., Schramm, G. E., Wills, A. R., Reichley, R. M., Micek, S. T., & Kollef, M. H. (2008) · Chest · doi:10.1378/chest.08-1116 · Cited by 237
Compartmentalization of the inflammatory response in sepsis and SIRS
Cavaillon, J.-M., & Annane, D. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x102246 · Cited by 233
Regulatory T cell populations in sepsis and trauma
Venet, F., Chung, C.-S., Monneret, G., Huang, X., Horner, B., Garber, M., & Ayala, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607371 · Cited by 230
Inoue, S., Unsinger, J., Davis, C. G., Muenzer, J. T., Ferguson, T. A., Chang, K., Osborne, D. F., Clark, A. T., Coopersmith, C. M., McDunn, J. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902307 · Cited by 229
Self-citationClinical Trials of Immunomodulatory Therapies in Severe Sepsis and Septic Shock
Vincent, J., Sun, Q., & Dubois, M. (2002) · Clinical Infectious Diseases · doi:10.1086/339549 · Cited by 228
Sportès, C., Babb, R. R., Krumlauf, M. C., Hakim, F. T., Steinberg, S. M., Chow, C. K., Brown, M. R., Fleisher, T. A., Noel, P., Maric, I., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1303 · Cited by 227
Bo, L., Wang, F., Zhu, J., Li, J., & Deng, X. (2011) · Critical Care · doi:10.1186/cc10031 · Cited by 219
Efficacy and Safety of Renal Tubule Cell Therapy for Acute Renal Failure
Tumlin, J., Wali, R., Williams, W., Murray, P., Tolwani, A. J., Vinnikova, A. K., Szerlip, H. M., Ye, J., Paganini, E. P., Dworkin, L., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007080895 · Cited by 214
Kalil, A. C., & Florescu, D. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a3aa43 · Cited by 208
Nelson, S., Belknap, S. M., Carlson, R. W., Dale, D., DeBoisblanc, B., Farkas, S., Fotheringham, N., Ho, H., Marrie, T., Movahhed, H., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515694 · Cited by 204
IL-7 Restores Lymphocyte Functions in Septic Patients
Venet, F., Foray, A.-P., Villars-Méchin, A., Malcus, C., Poitevin-Later, F., Lepape, A., & Monneret, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202062 · Cited by 199
Root, R. K., Lodato, R. F., Patrick, W., Cade, J. F., Fotheringham, N., Milwee, S., Vincent, J.-L., Torres, A., Rello, J., & Nelson, S. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000048629.32625.5d · Cited by 196
He, K.-L., & Ting, A. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6034-6045.2002 · Cited by 196
Mechanisms of Mortality in Early and Late Sepsis
Xiao, H., Siddiqui, J., & Remick, D. G. (2006) · Infection and Immunity · doi:10.1128/iai.01220-05 · Cited by 194
Polk, H. C., Cheadle, W. G., Livingston, D. H., Rodriguez, J. L., Starko, K. M., Izu, A. E., Jaffe, H. S., & Sonnenfeld, G. (1992) · The American Journal of Surgery · doi:10.1016/0002-9610(92)90099-d · Cited by 178
Attenuating Lymphocyte Activity
Compaan, D. M., Gonzalez, L. C., Tom, I., Loyet, K. M., Eaton, D., & Hymowitz, S. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507629200 · Cited by 170
Genome-wide transcription profiling of human sepsis: a systematic review
Tang, B. M., Huang, S. J., & McLean, A. S. (2010) · Critical Care · doi:10.1186/cc9392 · Cited by 169
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2012) · Survey of Anesthesiology · doi:10.1097/sa.0b013e3182751ec1 · Cited by 167
Self-citationCytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis
Heininger, A., Haeberle, H., Fischer, I., Beck, R., Riessen, R., Rohde, F., Meisner, C., Jahn, G., Koenigsrainer, A., Unertl, K., et al. (2011) · Critical Care · doi:10.1186/cc10069 · Cited by 160
IL-7 in human health and disease
Lundström, W., Fewkes, N. M., & Mackall, C. L. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.02.005 · Cited by 159
Venet, F., Pachot, A., Debard, A.-L., Bohe, J., Bienvenu, J., Lepape, A., Powell, W. S., & Monneret, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6540 · Cited by 158
Multiple triggers of cell death in sepsis: death receptor and mitochondrial‐mediated apoptosis
Chang, K. C., Unsinger, J., Davis, C. G., Schwulst, S. J., Muenzer, J. T., Strasser, A., & Hotchkiss, R. S. (2007) · The FASEB Journal · doi:10.1096/fj.06-6805com · Cited by 157
Self-citationOverexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice
Coopersmith, C. M., Chang, K. C., Swanson, P. E., Tinsley, K. W., Stromberg, P. E., Buchman, T. G., Karl, I. E., & Hotchkiss, R. S. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00028 · Cited by 154
Self-citationImmunoparalysis and Adverse Outcomes from Critical Illness
Frazier, W. J., & Hall, M. W. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.02.009 · Cited by 152
BALK, R. A. (2000) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70113-5 · Cited by 152
Savoldo, B., Huls, M. H., Liu, Z., Okamura, T., Volk, H., Reinke, P., Sabat, R., Babel, N., Jones, J. F., Webster-Cyriaque, J. Y., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0039 · Cited by 149
Why do animal models (sometimes) fail to mimic human sepsis?
Esmon, C. T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000127036.27343.48 · Cited by 146
Arad, G., Levy, R., Nasie, I., Hillman, D., Rotfogel, Z., Barash, U., Supper, E., Shpilka, T., Minis, A., & Kaempfer, R. O. R. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001149 · Cited by 142
Effect of Interferon Gamma on Infection-Related Death in Patients With Severe Injuries
Dries, D. J. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420340045008 · Cited by 138
Akt Decreases Lymphocyte Apoptosis and Improves Survival in Sepsis
Bommhardt, U., Chang, K. C., Swanson, P. E., Wagner, T. H., Tinsley, K. W., Karl, I. E., & Hotchkiss, R. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7583 · Cited by 134
Self-citationSepsis studies need new direction
Cohen, J., Opal, S. M., & Calandra, T. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70136-6 · Cited by 132
Interleukin-7 Ameliorates Immune Dysfunction and Improves Survival in a 2-Hit Model of Fungal Sepsis
Unsinger, J., Burnham, C. D., McDonough, J. S., Morre, M., Prakash, P. S., Caldwell, C. C., Dunne, W. M., & Hotchkiss, R. S. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis383 · Cited by 131
Self-citationKitazawa, Y., Fujino, M., Wang, Q., Kimura, H., Azuma, M., Kubo, M., Abe, R., & Li, X. (2007) · Transplantation · doi:10.1097/01.tp.0000256293.90270.e8 · Cited by 130
Prospects for TIM3-Targeted Antitumor Immunotherapy
Ngiow, S. F., Teng, M. W. L., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1487 · Cited by 128
Kasten, K. R., Prakash, P. S., Unsinger, J., Goetzman, H. S., England, L. G., Cave, C. M., Seitz, A. P., Mazuski, C. N., Zhou, T. T., Morre, M., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00456-10 · Cited by 128
Self-citationLázár‐Molnár, E., Gácser, A., Freeman, G. J., Almo, S. C., Nathenson, S. G., & Nosanchuk, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711918105 · Cited by 125
The CD4-like molecule LAG-3, biology and therapeutic applications
Sierro, S. R., Romero, P. J., & Speiser, D. E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14712598.2011.540563 · Cited by 121
Memory T Cells and Their Costimulators in Human Allograft Injury
Shiao, S. L., McNiff, J. M., & Pober, J. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.4886 · Cited by 112
T helper cell subset ratios in patients with severe sepsis
Ferguson, N. R., Galley, H. F., & Webster, N. R. (1999) · Intensive Care Medicine · doi:10.1007/s001340050795 · Cited by 109
Cheng, A. C., Limmathurotsakul, D., Chierakul, W., Getchalarat, N., Wuthiekanun, V., Stephens, D. P., Day, N., White, N. J., Chaowagul, W., Currie, B. J., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/519261 · Cited by 105
Weighardt, H., Heidecke, C.-D., Emmanuilidis, K., Maier, S., Bartels, H., Siewert, J., & Holzmann, B. (2000) · Surgery · doi:10.1067/msy.2000.104118 · Cited by 103
Sepsis-induced human lymphocyte apoptosis and cytokine production in “humanized” mice
Unsinger, J., McDonough, J. S., Shultz, L. D., Ferguson, T. A., & Hotchkiss, R. S. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008615 · Cited by 99
Self-citationRole of Toll-like receptor responses for sepsis pathogenesis
Weighardt, H., & Holzmann, B. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.09.010 · Cited by 98
Shubin, N. J., Chung, C. S., Heffernan, D. S., Irwin, L. R., Monaghan, S. F., & Ayala, A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211641 · Cited by 97
Venet, F., Lepape, A., & Monneret, G. (2011) · Critical Care · doi:10.1186/cc10333 · Cited by 96
Rosenbloom, A. J., Linden, P. K., Dorrance, A. M., Penkosky, N., Cohen-Melamed, M. H., & Pinsky, M. R. (2005) · CHEST Journal · doi:10.1378/chest.127.6.2139 · Cited by 91
ICU-acquired immunosuppression and the risk for secondary fungal infections
Monneret, G., Venet, F., Kullberg, B. J., & Netea, M. G. (2010) · Medical Mycology · doi:10.3109/13693786.2010.509744 · Cited by 90
Coupled plasma filtration adsorption
Bellomo, R., Tetta, C., & Ronco, C. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1796-x · Cited by 88
Increased mortality in long-term intensive care patients with active cytomegalovirus infection*
Ziemann, M., Sedemund‐Adib, B., Reiland, P., Schmucker, P., & Hennig, H. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f3fc4 · Cited by 88
C5a receptor and thymocyte apoptosis in sepsis
Riedemann, N. C., Guo, R., Laudes, I. J., Keller, K. A., Sarma, V. J., Padgaonkar, V. A., Zetoune, F. S., & Ward, P. A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0033fje · Cited by 86
Rigato, O., & Salomão, R. (2003) · Shock · doi:10.1097/00024382-200302000-00004 · Cited by 85
Nelson, S., Heyder, A., Stone, J., Bergeron, M. G., Daugherty, S. K., Peterson, G. M., Fotheringham, N., Welch, W., Milwee, S., Root, R. K., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315775 · Cited by 82
Chronic Sepsis Mortality Characterized by an Individualized Inflammatory Response
Osuchowski, M. F., Welch, K. B., Yang, H., Siddiqui, J., & Remick, D. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.623 · Cited by 82
Unsinger, J., Kazama, H., McDonough, J. S., Griffith, T. S., Hotchkiss, R. S., & Ferguson, T. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904054 · Cited by 79
Self-citationRice, T. W., Wheeler, A. P., Morris, P. E., Paz, H. L., Russell, J. A., Edens, T. R., & Bernard, G. R. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000230385.82679.34 · Cited by 73
Stephens, D. P., Thomas, J. H., Higgins, A. M., Bailey, M., Anstey, N. M., Currie, B. J., & Cheng, A. C. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0b013e318161e480 · Cited by 66
Mechanism of T cell exhaustion in a chronic environment
Jin, H.-T., Jeong, Y. H., Park, H.-J., & Ha, S. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.4.217 · Cited by 63
Immunomodulatory therapy for sepsis: an update
Christaki, E., Anyfanti, P., & Opal, S. M. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.122 · Cited by 61
IMMUNOLOGIC RESPONSE TO INFECTION AND ITS ROLE IN SEPTIC SHOCK
Casey, L. C. (2000) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70107-x · Cited by 58
Morre, M., & Beq, S. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0210-4 · Cited by 56
The immune response to severe bacterial infections: consequences for therapy
Giamarellos‐Bourboulis, E. J., & Raftogiannis, M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.2 · Cited by 55
The role of T regulatory cells in human sepsis
Kessel, A., Bamberger, E., Masalha, M., & Toubi, E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.014 · Cited by 54
Downregulation of CD40 Ligand Response in Monocytes from Sepsis Patients
Sinistro, A., Almerighi, C., Ciaprini, C., Natoli, S., Sussarello, E., Fino, S. D., Calò-Carducci, F., Rocchi, G., & Bergamini, A. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00184-08 · Cited by 52
Schefold, J. C., Zeden, J.-P., Pschowski, R., Hammoud, B., Fotopoulou, C., Hasper, D., Fusch, G., von Haehling, S., Volk, H., Meisel, C., et al. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903405768 · Cited by 49
Flohé, S. B., Agrawal, H., Flohé, S., Rani, M., Bangen, J. M., & Schade, F. U. (2008) · Molecular Medicine · doi:10.2119/2007-00120.flohe · Cited by 44
Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations
BALK, R. A. (2004) · Disease-a-Month · doi:10.1016/j.disamonth.2003.12.003 · Cited by 44
Schmidt, M. V., Paulus, P., Kühn, A., Weigert, A., Morbitzer, V., Zacharowski, K. D., Kempf, V. A. J., Brüne, B., & von Knethen, A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1585oc · Cited by 42
A Historical Perspective on Sepsis
Ward, P. A., & Bosmann, M. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.05.003 · Cited by 38
Immunologic Alterations and the Pathogenesis of Organ Failure in the ICU
Opal, S. M. (2011) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0031-1287865 · Cited by 33
A rapidly progressing lymphocyte exhaustion after severe sepsis
Monneret, G., & Venet, F. (2012) · Critical Care · doi:10.1186/cc11416 · Cited by 28
Surviving sepsis:bcl-2 overexpression modulates splenocyte transcriptional responses in vivo
Wagner, T. H., Drewry, A. M., MacMillan, S., Dunne, W. M., Chang, K. C., Karl, I. E., Hotchkiss, R. S., & Cobb, J. P. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00656.2006 · Cited by 17
Self-citationKlener, P., Anděra, L., Klener, P., Nečas, E., & Živný, J. (2006) · Folia Biologica · doi:10.14712/fb2006052040119 · Cited by 15
Recombinant Human Activated Protein C as a Therapy for Severe Sepsis: Lessons Learned?
Opal, S. M., & LaRosa, S. P. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0505ed · Cited by 11
Cited by
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
Qin, W., Hu, L., Zhang, X., Jiang, S., Li, J., Zhang, Z., & Wang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02298 · Cited by 369
Sepsis-Induced Immunosuppression
Torres, L. K., Pickkers, P., & van der Poll, T. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061121-040214 · Cited by 355
Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis
Nedeva, C. (2021) · Biomolecules · doi:10.3390/biom11071011 · Cited by 265
Bektas, A., Schurman, S. H., Franceschi, C., & Ferrucci, L. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00196-8 · Cited by 102
One population, multiple lifestyles: Commensalism and pathogenesis in the human mycobiome
Proctor, D. M., Drummond, R. A., Lionakis, M. S., & Segre, J. A. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.02.010 · Cited by 68
Metadata
- Authors
- Boomer, J. S., Green, J. M., & Hotchkiss, R. S.
- Venue
- Virulence
- Publisher
- Informa UK Limited
- Published
- 2013-09-25
- Volume
- 5
- Issue
- 1
- Pages
- 45-56
- ISSN
- 2150-5594 (ISSN-L)
- 2150-5608
- OpenAlex
- W2061730726
- Cited by
- 317
- References
- 147
- FWCI
- 12.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.